Skip to main content
. 2020 Jun 8;272(3):e219–e221. doi: 10.1097/SLA.0000000000004114

TABLE 1.

Important Considerations in Deciding When to Suspend a Clinical Trial During the COVID-19 Pandemic1

graphic file with name ansu-272-e219-g002.jpg